Clinical trials recruiting for Leiomyosarcoma
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| H2 receptor antagonist | 1 |
| Nivolumab | 1 |
| OKN4395 | 1 |
| Pembrolizumab | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| South Dakota | 1 |
| Texas | 1 |
Top cities
Self-screener
Recruiting trials
- A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
- Agnostic Therapy in Rare Solid Tumors
- Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Related conditions
Trials recruiting for Leiomyosarcoma often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Leiomyosarcoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.